JD.com-backed JD Health hits 3-week high on buyback plan, strong results

JD Health International

29/03/2022 03:45

** Shares of pharmaceutical products and Internet healthcare
services provider JD Health International Inc  6618.HK  soar
16.3% to HK$48.80, highest since March 8, and on course for the
second session of gain
    ** Stock on track for the biggest daily percentage gain
since March 16; biggest percentage gainer in Hang Seng Tech
Index  .HSTECH , Hang Seng China Enterprises Index  .HSCE  and 
Hang Seng Composite Index  .HSCI  
    ** JD.com-backed  9618.HK  company says its board has
approved a programme to repurchase up to HK$3 bln ($383.23 mln)
worth of shares from the open market over a 24-month period to
demonstrate its confidence in its long-term business outlook and
prospects  urn:newsml:reuters.com:*:nFWN2VV0M3
    ** JD Health says its 2021 revenue jumped 58.3% year-on-year
to 30.68 bln yuan ($4.82 bln) with net loss narrowing to 1.07
bln yuan from 2020's 17.23 bln yuan loss and gross profit up
46.4% to 7.2 bln yuan  urn:newsml:reuters.com:*:nFWN2VT0GC
    ** Nomura says JD Health's 2H21 revenue and earnings both
beat 
    ** JD.com  9618.HK  Hong Kong shares climb 1.4%   
    ** Hang Seng Tech Index  .HSTECH  rises 1.2%, Hang Seng
Composite Index  .HSCI  gains 0.4%
    ** Hang Seng China Enterprises Index  .HSCE  climbs 0.7%, 
Hang Seng Index  .HSI  up 0.4%



($1 = 7.8281 Hong Kong dollars)

($1 = 6.3671 Chinese yuan renminbi)

 (Reporting by Donny Kwok)
 ((donny.kwok@thomsonreuters.com))